Europe OTC Drug and Dietary Supplement Market to Grow at a CAGR of 6.6% to reach US$ 141,676.3 Million from 2020 to 2027

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe OTC Drug and Dietary Supplement Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe OTC Drug and Dietary Supplement Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Growing Preference for Non-Prescription Drugs over Prescription Drugs
5.1.2 Growing prevalence of infectious diseases

5.2 Market Opportunities

5.2.1 R&D Activities by Market Players to Offer Improved OTC Drugs

5.3 Future Trends

5.3.1 N/A

5.4 Impact of Drivers and Restraints

6. Europe OTC Drug and Dietary Supplement Market Regional Analysis

6.1 Europe OTC Drug and Dietary Supplement Market Overview

6.2 Europe OTC Drug and Dietary Supplement Market Revenue 2017-2027 (US$ Million)

6.3 Europe OTC Drug and Dietary Supplement Market Forecast Analysis

7. Europe OTC Drug and Dietary Supplement Market Analysis – by Product

7.1 Cough and Cold Products

7.1.1 Overview
7.1.2 Cough and Cold Products: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Vitamins and Dietary Supplements

7.2.1 Overview
7.2.2 Vitamins and Dietary Supplements: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Analgesics

7.3.1 Overview
7.3.2 Analgesics: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Gastrointestinal Products

7.4.1 Overview
7.4.2 Gastrointestinal Products: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Sleep Aids

7.5.1 Overview
7.5.2 Sleep Aids: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)

7.6 Oral Care Products

7.6.1 Overview
7.6.2 Oral Care Products: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)

7.7 Ophthalmic Products

7.7.1 Overview
7.7.2 Ophthalmic Products: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)

7.8 Antacids

7.8.1 Overview
7.8.2 Antacids: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)

7.9 Feminine Care

7.9.1 Overview
7.9.2 Feminine Care: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe OTC Drug and Dietary Supplement Market Analysis – by Type

8.1 Branded and Generic

8.1.1 Overview
8.1.2 Branded and Generic: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)

9. Europe OTC Drug and Dietary Supplement Market Analysis – by Form

9.1 Tablets

9.1.1 Overview
9.1.2 Branded and Generic: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Capsules

9.2.1 Overview
9.2.2 Branded and Generic: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)

9.3 Powders

9.3.1 Overview
9.3.2 Branded and Generic: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)

9.4 Ointments

9.4.1 Overview
9.4.2 Branded and Generic: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)

9.5 Liquid

9.5.1 Overview
9.5.2 Branded and Generic: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)

10. Europe OTC Drug and Dietary Supplement Market – Europe Analysis

10.1 Europe

10.1.1 Europe OTC Drug and Dietary Supplement Market Breakdown, by Key Country, 2020 and 2027 (%)
10.1.1.1 Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 UK: Europe OTC Drug and Dietary Supplement Market Breakdown, by Product
10.1.1.1.2 UK: Europe OTC Drug and Dietary Supplement Market Breakdown, by Type
10.1.1.1.3 UK: Europe OTC Drug and Dietary Supplement Market Breakdown, by Form

10.1.1.2 Germany: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Germany: Europe OTC Drug and Dietary Supplement Market Breakdown, by Product
10.1.1.2.2 Germany: Europe OTC Drug and Dietary Supplement Market Breakdown, by Type
10.1.1.2.3 Germany: Europe OTC Drug and Dietary Supplement Market Breakdown, by Form

10.1.1.3 France: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 France: Europe OTC Drug and Dietary Supplement Market Breakdown, by Product
10.1.1.3.2 France: Europe OTC Drug and Dietary Supplement Market Breakdown, by Type
10.1.1.3.3 France: Europe OTC Drug and Dietary Supplement Market Breakdown, by Form

10.1.1.4 Russia: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.4.1 Russia: Europe OTC Drug and Dietary Supplement Market Breakdown, by Product
10.1.1.4.2 Russia: Europe OTC Drug and Dietary Supplement Market Breakdown, by Type
10.1.1.4.3 Russia: Europe OTC Drug and Dietary Supplement Market Breakdown, by Form

10.1.1.5 Italy: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.5.1 Italy: Europe OTC Drug and Dietary Supplement Market Breakdown, by Product
10.1.1.5.2 Italy: Europe OTC Drug and Dietary Supplement Market Breakdown, by Type
10.1.1.5.3 Italy: Europe OTC Drug and Dietary Supplement Market Breakdown, by Form

10.1.1.6 Rest of Europe: Europe OTC Drug and Dietary Supplement Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe OTC Drug and Dietary Supplement Market Breakdown, by Product
10.1.1.6.2 Rest of Europe: Europe OTC Drug and Dietary Supplement Market Breakdown, by Type
10.1.1.6.3 Rest of Europe: Europe OTC Drug and Dietary Supplement Market Breakdown, by Form

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe OTC Drug and Dietary Supplement Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 GlaxoSmithKline plc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Sanofi

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Johnson and Johnson Services, Inc.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Abbott

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 AbbVie Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Bausch Health Companies Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Bayer AG

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Procter & Gamble

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Novartis AG

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Reckitt Benckiser Group Plc

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights